Dr. Nora Cutcliffe Email & Phone Number

Proven consulting capabilities in: 1) Writing policy papers (e.g. to advance market access strategy) for national/provincial biopharma industry associations, medical associations, and vaccine manufacturers; 2) Developing medical communications (e.g. journal publications & collaterals) and Key Opinion Leaders (KOLs) for Continuing Medical Education (CME) programs; 3) Developing Public Relations (PR), Investor Relations (IR) and Government Relations (GR) materials for… Show more Proven consulting capabilities in: 1) Writing policy papers (e.g. to advance market access strategy) for national/provincial biopharma industry associations, medical associations, and vaccine manufacturers; 2) Developing medical communications (e.g. journal publications & collaterals) and Key Opinion Leaders (KOLs) for Continuing Medical Education (CME) programs; 3) Developing Public Relations (PR), Investor Relations (IR) and Government Relations (GR) materials for privately-held and publicly-traded biopharma companies; 4) Assessing market opportunity & competitive positioning for biopharma therapeutics, particularly to support potential investment (or due diligence processes);5) Writing technical reports for Scientific Research & Experimental Development (SR&ED) tax claims. Show less

Dr. Cutcliffe held progressively senior roles in Market Development/Research, Business Development, and Marketing/Communications, as Hemosol raised ~$250 M in equity financing (TSX & NASDAQ), and as HEMOLINK, an oxygen therapeutic, advanced from preclinical through Phase III (international) clinical trials in orthopaedic and cardiovascular surgery. Most senior role was Associate Director, Communications, Oct. 2000 - June 2002, reporting to VP Marketing, supervising 3 US reportees, managing… Show more Dr. Cutcliffe held progressively senior roles in Market Development/Research, Business Development, and Marketing/Communications, as Hemosol raised ~$250 M in equity financing (TSX & NASDAQ), and as HEMOLINK, an oxygen therapeutic, advanced from preclinical through Phase III (international) clinical trials in orthopaedic and cardiovascular surgery. Most senior role was Associate Director, Communications, Oct. 2000 - June 2002, reporting to VP Marketing, supervising 3 US reportees, managing budget ~$500 K/yr. Show less

Ph.D., School Of Business; Double Major In Operations Research (Management Science) & Management Accounting

Scholarships: i) NSERC 1967 Centennial Scholarship; ii) Queen’s Faculty of Graduate Studies Award

M.Sc., Biochemistry/Neurophysiology

Scholarships: i) NSERC 1967 Centennial Scholarship; ii) U.K. Overseas Research Scholarship

B.Sc., Biochemistry

Distinctions: i) Governor-General's Gold Medal, awarded to the leading First Class Honours Graduate of Dalhousie University, 1984; ii).

B.Sc., Biochemistry

Distinctions: i) Junior Year Abroad Award (3rd year of B.Sc.), Univ. of Stirling, Scotland